🇺🇸 FDA
Pipeline program

CEA-targeted CAR-T cells

PBC094

Phase 1 mab active

Quick answer

CEA-targeted CAR-T cells for Lung Cancer is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Lung Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials